Diabetes Diagnostics

Diabetes Diagnostics

Global Diabetes Diagnostics Market to Reach $45.6 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Diabetes Diagnostics estimated at US$26.5 Billion in the year 2020, is projected to reach a revised size of US$45.6 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Test Strips, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$11.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lancets segment is readjusted to a revised 7.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.1 Billion, While China is Forecast to Grow at 9.7% CAGR
The Diabetes Diagnostics market in the U.S. is estimated at US$10.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.9 Billion by the year 2027.

Analog Glucose Monitors Segment to Record 6.7% CAGR
In the global Analog Glucose Monitors segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.5% CAGR through the analysis period.

Select Competitors (Total 91 Featured) -

  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care, Inc.
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Beckman Coulter, Inc.
  • HemoCue® AB
  • DexCom, Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co., Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers
  • Sinocare, Inc.
  • PTS Diagnostics
  • Trividia Health, Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech plc
  • Ypsomed AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of COVID-19 and a Looming Global Recession
Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management
Diabetes: A Chronic Body Disorder
An Introduction to Diabetes Diagnostics
Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Developed Regions Lead, Developing Economies to Spearhead Future Growth
Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
World Diabetes Prevalence (2000-2019)
Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Diabetes Emerges as One of the Leading Causes of Mortality
Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
Competition
Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019
Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019
Quality Products at Low Prices: Mantra for Success in the Marketplace
SMBG Makers Turn to Mobile Devices to Woo Users on the Move
World Brands
Recent Market Activity
Diabetes Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Diabetes-Related Health Expenditure: Average Spending Per Person (in US$) by Region for 2010 and 2019
Increasing Obesity Levels Underpins Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
Global Continuous Glucose Monitoring Systems Market by Component for 2020E
Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2020E
CGM Demand Benefits from the COVID-19 Pandemic
CGM Market Breaks through Barriers to Witness Growing Adoption
Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Glycated Albumin: A Potential Threat to HbA1c
Role of HbA1c Testing in Diabetes Diagnosis and Management
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
Blood Sugar Lancets Market: Sustained Growth in Demand
Self-Monitoring/Household Blood Glucose Sustains Market Growth
Rising Smartphone Penetration Augurs Well for SMBG Market
Smartphone Penetration Rate as Share of Total Population: 2016-2020
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Insulin Pens Rise in Popularity for Administering Insulin
Smart Insulin Pens
Increasing Role of Self-Injection Devices in Diabetes Management
Prefilled Syringe Pen Injectors
Human Factors Influence the Design of Self Injection Systems
Pain Free Shots: A Growing R&D Domain
Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Innovations & Product Advancements: Prime Focus Area for Vendors
Focus on Development of Wearable Devices
An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
Companies Develop Innovative Needle-Free Alternatives
mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Innovations in Insulin Pumps
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 34: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
Diabetes Prevalence by Ethnicity: 2019
Aging Demographics: A Factor Driving Diabetes Prevalence
Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
North American Aging Population (in Thousands) by Age Group: 1975-2050
Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019
Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
Regulatory Guidance for Glucose Meter Companies
Insulin Syringes Dominate the Insulin Delivery Devices Market
Emerging Grey Market for Testing Strips
Competition
Companies Focus on Research for Better Diabetes Diagnostics
TABLE 40: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: USA Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: USA 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 43: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: USA Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: USA 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
TABLE 46: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Canada Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Canada 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 49: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Canada Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Canada 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Aging Population Drives Diabetes Diagnostics Market
Diabetes Statistics in Japan (2019): Number of Adults with Diabetes (in ‘000s), Adults with Undiagnosed Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in ‘000s)
TABLE 52: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Japan 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 55: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Japan Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Japan 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Increasing Diabetes Incidence Drives Market Growth
Diabetes Statistics in China for 2019
Lower Penetration Offers High Growth Potential
Chinese Glucose Meters Breakdown of Revenues by Leading Companies for 2019
TABLE 58: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 61: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: China Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: China 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Diabetes Diagnostics Market in Europe: A Promising Outlook
Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
Diabetes Statistics in Europe (2019): Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries
Reimbursement Scenario
TABLE 64: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 67: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 70: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 73: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: France Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: France 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 76: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: France 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 79: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: Germany Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: Germany 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 82: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Germany Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Germany 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 85: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Italy Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Italy 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 88: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Italy Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Italy 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Market Overview
Diabetic Foot Ulcers in UK
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 91: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: UK Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: UK 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 94: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: UK Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: UK 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
TABLE 97: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Spain Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Spain 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 100: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Spain Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Spain 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
TABLE 103: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: Russia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Russia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 106: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Russia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Russia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 109: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Rest of Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Rest of Europe 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Rest of Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Rest of Europe 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
Diabetes and Population Statistics in South East Asia (2019 & 2045)
Diabetes and Population Statistics in Western Pacific (2019 & 2045)
Diabetes Statistics in Select Asia-Pacific Countries: Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for 2019
Public and Private Sector Diabetes Care
TABLE 115: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 116: Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 121: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 124: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Australia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Australia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 127: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Australia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Australia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Expanding Diabetic Population Spurs Growth in the Indian Market
Blood Glucose Monitoring Market: An Overview
HbA1c Testing Continues to Gain Momentum
Glucose Meters Rely on Imported Technology
TABLE 130: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: India Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: India 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 133: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: India Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: India 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 136: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: South Korea Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: South Korea 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 139: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: South Korea Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: South Korea 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 142: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Rest of Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 145: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Rest of Asia-Pacific 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
Diabetes and Population Statistics in South & Central America (2019 & 2045)
TABLE 148: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 149: Latin America Historic Review for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Latin America 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 151: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Latin America 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 154: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Latin America 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 157: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Argentina Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Argentina 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 160: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Argentina Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Argentina 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
BRAZIL
TABLE 163: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Brazil Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Brazil 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 166: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: Brazil Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Brazil 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
MEXICO
TABLE 169: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: Mexico Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Mexico 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 172: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Mexico Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Mexico 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 175: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Rest of Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Rest of Latin America 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 178: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Rest of Latin America 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 181: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 182: Middle East Historic Review for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Middle East 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 184: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Middle East 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 187: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Middle East 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
IRAN
TABLE 190: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Iran Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Iran 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 193: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Iran Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Iran 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ISRAEL
TABLE 196: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Israel Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Israel 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 199: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Israel Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Israel 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 202: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Saudi Arabia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Saudi Arabia 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 205: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Saudi Arabia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Saudi Arabia 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 208: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: UAE Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: UAE 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 211: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: UAE Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 213: UAE 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 214: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 215: Rest of Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 216: Rest of Middle East 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 217: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 218: Rest of Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 219: Rest of Middle East 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
AFRICA
Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 220: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 221: Africa Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 222: Africa 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027
TABLE 223: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 224: Africa Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 225: Africa 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 91

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings